Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cassady Remy

1PUBLICATIONS

22CO-AUTHORS

Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 18, 2022

Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.

Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub

Pageof 1

Frequent Collaborators

1 joint publications

Jesus D Gonzalez-Lugo

1 joint publications

Suman Kambhampati

1 joint publications

Abdulraheem Yacoub

1 joint publications

William B Donnellan

1 joint publications

Jesus Berdeja

1 joint publications

Prafulla Bhagat

1 joint publications

Karen Fehn

1 joint publications

Sakshi Jasra

1 joint publications

Mohammed Kazemi

1 joint publications

Kith Pradhan

Frequent Collaborators

1 joint publications

Jesus D Gonzalez-Lugo

1 joint publications

Suman Kambhampati

1 joint publications

Abdulraheem Yacoub

1 joint publications

William B Donnellan

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

See more related videos

Top Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

See more related videos